Cargando…
Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome
IMPORTANCE: Observer-rated scales, such as the Finnegan Neonatal Abstinence Scoring Tool (FNAST), are used to quantify the severity of neonatal abstinence syndrome (NAS) and guide pharmacologic therapy. The FNAST, a comprehensive 21-item assessment tool, was developed for research and subsequently i...
Autores principales: | Devlin, Lori A., Breeze, Janis L., Terrin, Norma, Gomez Pomar, Enrique, Bada, Henrietta, Finnegan, Loretta P., O’Grady, Kevin E., Jones, Hendrée E., Lester, Barry, Davis, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142377/ https://www.ncbi.nlm.nih.gov/pubmed/32267513 http://dx.doi.org/10.1001/jamanetworkopen.2020.2275 |
Ejemplares similares
-
Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA
por: Gomez Pomar, Enrique, et al.
Publicado: (2017) -
59473 Clinical and demographic predictors of the need for pharmacotherapy in Neonatal Abstinence Syndrome (NAS)
por: Bibi, Shawana, et al.
Publicado: (2021) -
The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its’ Origins, Assessment, and Management
por: Gomez-Pomar, Enrique, et al.
Publicado: (2018) -
Polygenic Risk Scores and the Need for Pharmacotherapy in Neonatal Abstinence Syndrome
por: Bibi, Shawana, et al.
Publicado: (2023) -
EEG Findings in Infants With Neonatal Abstinence Syndrome Presenting With Clinical Seizures
por: Palla, Murali Reddy, et al.
Publicado: (2019)